Nuo Therapeutics, Inc. (AURX) Insider Trading
Sector: N/A · Market Cap: $63M · 0 insider purchases in the last 7 days
No open market insider purchases at Nuo Therapeutics, Inc. in the last 7 days.
Want more?
Sign up free to see 30+ days of history, set alerts, and track AURX on your watchlist.
Start for FreeAbout Nuo Therapeutics, Inc. Insider Trading
1 insider at Nuo Therapeutics, Inc. (AURX) has purchased stock in the past 90 days, totaling $10K across 2 transactions (8,773 shares).
The most recent purchase was by CEO JORDEN DAVID EMERSON on August 28, 2026 — a $9K buy of 7,984 shares at $1.09, bringing their total holdings to 2,070,000 shares.
This insider buying is notable given that AURX had no recorded open market purchases in the nine months before that.
AURX is in the N/A sector within the N/A industry with a market cap of $63M.
Track AURX insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.
More Insider Trading in N/A
Angel Oak Financial Strategies Income Term Trust
17 purchases (7d)
PCQPIMCO CALIFORNIA MUNICIPAL INCOME FUND
2 purchases (7d)
ECFELLSWORTH GROWTH & INCOME FUND LTD
13 purchases (7d)
GFNEW GERMANY FUND INC
99 purchases (7d)
NMCONuveen Municipal Credit Opportunities Fund
5 purchases (7d)
GRXGabelli Healthcare & WellnessRx Trust
39 purchases (7d)